Analysts have varying views on the stock, with 1 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for GUTS is 19.88M, and currently, shorts hold a 5.82% of that float. The average trading volume for GUTS on September 27, 2024 was 367.53K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
GUTS) stock’s latest price update
Fractyl Health Inc. (NASDAQ: GUTS)’s stock price has gone rise by 7.20 in comparison to its previous close of 2.36, however, the company has experienced a -6.99% decrease in its stock price over the last five trading days. globenewswire.com reported 2024-09-24 that BURLINGTON, Mass., Sept. 24, 2024 (GLOBE NEWSWIRE) — Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company”), a metabolic therapeutics company focused on pioneering new approaches that treat root causes of obesity and Type 2 Diabetes (T2D)), today announced that Harith Rajagopalan, M.D.
GUTS’s Market Performance
GUTS’s stock has fallen by -6.99% in the past week, with a monthly drop of -27.51% and a quarterly drop of -42.89%. The volatility ratio for the week is 9.46% while the volatility levels for the last 30 days are 9.38% for Fractyl Health Inc. The simple moving average for the past 20 days is -14.75% for GUTS’s stock, with a -55.89% simple moving average for the past 200 days.
Analysts’ Opinion of GUTS
Morgan Stanley, on the other hand, stated in their research note that they expect to see GUTS reach a price target of $18. The rating they have provided for GUTS stocks is “Overweight” according to the report published on February 27th, 2024.
BofA Securities gave a rating of “Buy” to GUTS, setting the target price at $26 in the report published on February 27th of the current year.
GUTS Trading at -16.65% from the 50-Day Moving Average
After a stumble in the market that brought GUTS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -82.55% of loss for the given period.
Volatility was left at 9.38%, however, over the last 30 days, the volatility rate increased by 9.46%, as shares sank -24.93% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -46.40% lower at present.
During the last 5 trading sessions, GUTS fell by -6.99%, in comparison to the 20-day moving average, which settled at $2.93. In addition, Fractyl Health Inc. saw -80.31% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at GUTS starting from Caplan Jay David, who sale 65,000 shares at the price of $2.90 back on Sep 12 ’24. After this action, Caplan Jay David now owns 30,484 shares of Fractyl Health Inc., valued at $188,474 using the latest closing price.
JAY D CAPLAN, the Officer of Fractyl Health Inc., proposed sale 65,000 shares at $2.85 during a trade that took place back on Sep 12 ’24, which means that JAY D CAPLAN is holding shares at $185,213 based on the most recent closing price.
Stock Fundamentals for GUTS
Current profitability levels for the company are sitting at:
- -599.84 for the present operating margin
- -2.67 for the gross margin
The net margin for Fractyl Health Inc. stands at -466.2. The total capital return value is set at -0.54.
Based on Fractyl Health Inc. (GUTS), the company’s capital structure generated 0.32 points at debt to capital in total, while cash flow to debt ratio is standing at -1.57.
Currently, EBITDA for the company is -50.55 million with net debt to EBITDA at 0.58. When we switch over and look at the enterprise to sales, we see a ratio of 669.97. The receivables turnover for the company is 5.41for trailing twelve months and the total asset turnover is 0.0. The liquidity ratio also appears to be rather interesting for investors as it stands at 7.46.
Conclusion
In conclusion, Fractyl Health Inc. (GUTS) has had a bad performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
